165 related articles for article (PubMed ID: 10235123)
1. Estrogen receptor as a target for the prevention of breast cancer.
Jordan VC
J Lab Clin Med; 1999 May; 133(5):408-14. PubMed ID: 10235123
[No Abstract] [Full Text] [Related]
2. Tamoxifen, raloxifene, and the prevention of breast cancer.
Jordan VC; Morrow M
Endocr Rev; 1999 Jun; 20(3):253-78. PubMed ID: 10368771
[No Abstract] [Full Text] [Related]
3. Current controversies in breast cancer management.
Morrow M; Jordan VC; Takei H; Gradishar WJ; Pierce LJ
Curr Probl Surg; 1999 Mar; 36(3):163-216. PubMed ID: 10089889
[No Abstract] [Full Text] [Related]
4. Designer estrogens.
Jordan VC
Sci Am; 1998 Oct; 279(4):60-7. PubMed ID: 9768522
[No Abstract] [Full Text] [Related]
5. Molecular biology of the estrogen receptor aids in the understanding of tamoxifen resistance and breast cancer prevention with raloxifene.
Jordan VC
Recent Results Cancer Res; 1998; 152():265-76. PubMed ID: 9928564
[No Abstract] [Full Text] [Related]
6. Breast cancer highlights.
Kuter I
Oncologist; 1999; 4(4):299-308. PubMed ID: 10476541
[No Abstract] [Full Text] [Related]
7. New hope for prevention, treatment of breast cancer.
Harv Health Lett; 1998 Aug; 23(10):6-7. PubMed ID: 9723013
[No Abstract] [Full Text] [Related]
8. Tamoxifen versus raloxifene in the prevention of breast cancer.
Wickerham DL
Eur J Cancer; 2002 Nov; 38 Suppl 6():S20-1. PubMed ID: 12409060
[No Abstract] [Full Text] [Related]
9. Encouraging news from the SERM frontier. Selective estrogen receptor modulator.
Franks AL; Steinberg KK
JAMA; 1999 Jun; 281(23):2243-4. PubMed ID: 10376579
[No Abstract] [Full Text] [Related]
10. Tamoxifen, raloxifene findings unlikely to encourage genetic screening for breast cancer.
Dove A
Nat Med; 1998 Jun; 4(6):647. PubMed ID: 9623955
[No Abstract] [Full Text] [Related]
11. Development of a new prevention maintenance therapy for postmenopausal women.
Jordan VC
Recent Results Cancer Res; 1999; 151():96-109. PubMed ID: 10337721
[TBL] [Abstract][Full Text] [Related]
12. In search of the perfect SERM: beyond tamoxifen and raloxifene.
McNeil C
J Natl Cancer Inst; 1998 Jul; 90(13):956-7. PubMed ID: 9665139
[No Abstract] [Full Text] [Related]
13. Breast cancer biology blossoms in the clinic.
Nass SJ; Hahm HA; Davidson NE
Nat Med; 1998 Jul; 4(7):761-2. PubMed ID: 9662357
[No Abstract] [Full Text] [Related]
14. Tamoxifen debate hinges on whose risk is high enough.
Reynolds T
J Natl Cancer Inst; 1998 Oct; 90(19):1428-30. PubMed ID: 9776407
[No Abstract] [Full Text] [Related]
15. Until there's more information, caution advised in using tamoxifen or raloxifene for breast cancer prevention.
Mayo Clin Health Lett; 1998 Jul; 16(7):4. PubMed ID: 9663019
[No Abstract] [Full Text] [Related]
16. Breast cancer chemoprevention.
Mamounas EP
Hematol Oncol Clin North Am; 2000 Jun; 14(3):727-38. PubMed ID: 11203331
[No Abstract] [Full Text] [Related]
17. Tamoxifen for prevention of breast cancer.
Med Lett Drugs Ther; 1999 Jan; 41(1043):1-2. PubMed ID: 9924486
[No Abstract] [Full Text] [Related]
18. Progress in the prevention of breast cancer: concept to reality.
Jordan VC
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):269-77. PubMed ID: 11162935
[TBL] [Abstract][Full Text] [Related]
19. STAR trial reports.
Eur J Cancer; 2006 Aug; 42(12):1694. PubMed ID: 16998956
[No Abstract] [Full Text] [Related]
20. Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow.
Jordan VC
J Natl Cancer Inst; 1998 Jul; 90(13):967-71. PubMed ID: 9665143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
